sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
26-Mar-2015 18:30
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 76-100 out of 979.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>

Public Release: 20-Feb-2015
LSU researcher receives $1.8 million NIH grant to study proteins in rickettsial species
Juan J. Martinez, Ph.D., associate professor in the Department of Pathobiological Sciences at the LSU School of Veterinary Medicine, has been awarded a five-year grant from the National Institutes of Health, National Institute of Allergy and Infectious Disease to further understand the contribution of a family of outer-membrane proteins termed surface cell antigens, expressed by pathogenic rickettsial species to the initiation and progression of disease in animals and humans.
National Institutes of Health, NIH/National Institute of Allergy and Infectious Disease

Contact: Ginger Guttner
ginger@lsu.edu
225-578-9922
Louisiana State University

Public Release: 19-Feb-2015
Zoonoses and Public Health
Study exposes shocking lack of rabies reporting in countries where risk is greatest
The first global survey of rabies reporting systems, published this week, has uncovered a shocking lack of preparedness against this deadly disease across Africa and Asia. Accurate reporting of rabies cases to authorities is a critical first step in controlling rabies and preventing further outbreaks, yet the study found that over 2.5 billion people live in countries without effective rabies reporting.
UBS Optimus Foundation

Contact: Louise Taylor
media@rabiesalliance.org
Global Alliance for Rabies Control

Public Release: 19-Feb-2015
Lancet Infectious Diseases
Study in Myanmar confirms artemisinin-resistant malaria close to border with India
Resistance to the antimalarial drug artemisinin is established in Myanmar and has reached within 25km of the Indian border, a study published today in Lancet Infectious Diseases reports. Artemisinin resistance threatens to follow the same historical trajectory from Southeast Asia to the Indian subcontinent as seen in the past with other antimalarial medicines.

Contact: Clare Ryan
c.ryan@wellcome.ac.uk
44-020-761-17262
Wellcome Trust

Public Release: 18-Feb-2015
Journal of Clinical Investigation
Possible strategy identified to combat major parasitic tropical disease
Research led by St. Jude Children's Research Hospital scientists has identified a potential target in the quest to develop a more effective treatment for leishmaniasis, a parasitic tropical disease that kills thousands and sickens more than 1 million people worldwide each year. The findings were published online in the Journal of Clinical Investigation.
National Institutes of Health, European Research Council, Fund for Scientific Research-Flanders, American Lebanese Syrian Associated Charities

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital

Public Release: 18-Feb-2015
Disaster Medicine and Public Health Preparedness
Ebola and the International Health Regulations Treaty
The West Africa Ebola outbreak has shone a spotlight on lapses in the 2007 International Health Regulations Treaty, which was intended to improve the capacity of all countries to detect, assess, notify, and respond to public health threats of international concern.

Contact: Alice O'Donnell
dmphpjournal@gmail.com
240-833-4429
Society for Disaster Medicine and Public Health

Public Release: 17-Feb-2015
Journal of Pharmacology and Experimental Therapeutics
Nicotine metabolite amplifies action of the primary chemical messenger for learning and memory
Nicotine's primary metabolite supports learning and memory by amplifying the action of a primary chemical messenger involved in both, researchers report.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 15-Feb-2015
2015 AAAS Annual Meeting
An Italian cemetery may provide clues on cholera's evolution
A team of archaeologists and other researchers hope that an ancient graveyard in Italy can yield clues about the deadly bacterium that causes cholera.

Contact: Jeff Grabmeier
grabmeier.1@osu.edu
614-292-8457
Ohio State University

Public Release: 13-Feb-2015
2015 AAAS Annual Meeting
Lighting up a new path for novel synthetic polio vaccine
Scientists from the UK and USA are using technology that helped in the design of a new synthetic vaccine to combat the foot and mouth disease virus to target the virus that causes polio. The vaccine for FMDV does not contain the viral genome but instead 'mimics' the structure of the live virus. This project is being funded by a £438,000 grant from the World Health Organisation and Bill & Melinda Gates Foundation.
World Health OrganisationBill and Melinda Gates Foundation

Contact: Silvana Westbury
silvana.westbury@diamond.ac.uk
44-079-205-94660
Diamond Light Source

Public Release: 12-Feb-2015
Emerging Infectious Diseases
NIH Ebola study in macaques provides timeframes for post-mortem viral stability
To determine how long Ebola virus could remain infectious in a body after death, NIH scientists sampled deceased Ebola-infected monkeys and discovered the virus remained viable for at least seven days. They also detected non-infectious viral RNA for up to 70 days post-mortem.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Ken Pekoc
kpekoc@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 12-Feb-2015
Journal of Public Health Management and Practice
Ebola has lessons for local health departments' role in health crises
Experience with the Ebola outbreak highlights local health departments' essential role in responding to global health threats posed by infectious diseases, according to a special article in the March/April issue of the Journal of Public Health Management and Practice. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 12-Feb-2015
Viral Immunology
Ebola virus may have been present in West Africa long before 2014 outbreak
It is not known what triggered the transmission of Ebola virus from its natural host to humans and the rapid human-to-human spread of the deadly virus throughout Western Africa last year. However, analysis of the blood of patients in Sierra Leone suspected of having Lassa fever, a severe viral illness, between 2011-2014, showed prior exposure to Ebola virus, suggesting that Ebola was present in the area well before the recent outbreak, as reported in Viral Immunology.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 11-Feb-2015
Journal of Alzheimer's Disease
UM study finds air pollution affects short-term memory, IQ and brain metabolic ratios
City smog lowers children's IQ. This is among findings from a recent University of Montana study that found children living in cities with significant air pollution are at an increased risk for detrimental impacts to the brain, including short-term memory loss and lower IQ.

Contact: Dr. Lilian Calderón-Garcidueñas
lilian.calderon@mso.umt.edu
406-243-4785
The University of Montana

Public Release: 11-Feb-2015
Molecular Biology and Evolution
New research: Malaria parasites unlikely to jump from animals to humans
In recent years, public health experts have increasingly explored the idea of eliminating the most dangerous malaria-causing parasite. But they have questioned whether getting rid of this species, called Plasmodium falciparum, would allow other species of the parasite to simply jump into the gap and start infecting humans with malaria.

Contact: David Kohn
dkohn@som.umaryland.edu
410-706-7590
University of Maryland School of Medicine

Public Release: 11-Feb-2015
American Heart Association International Stroke Conference
Treating the uninjured side of the brain appears to aid stroke recovery
To maximize stroke recovery, researchers may want to focus more on ways to support the side of the brain where the injury didn't occur, scientists report.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 10-Feb-2015
Journal of Pediatric Gastroenterology and Nutrition
New approach to childhood malnutrition may reduce relapses, deaths
Children treated for moderate acute malnutrition experience a high rate of relapse and even death in the year following treatment and recovery. A study led by researchers at Washington University School of Medicine in St. Louis indicates that supplementary feeding for a set time period -- 12 weeks -- makes an impact but may not be as important as treating children until they reach target weights and measures of arm circumference.
US Agency for International Development

Contact: Elizabethe Holland Durando
elizabethe.durando@wustl.edu
314-286-0119
Washington University School of Medicine

Public Release: 10-Feb-2015
Lancet Psychiatry
1 in 5 suicides is associated with unemployment
Every year, around 45,000 people take their own lives because they are out of work or someone close to them is affected by unemployment, as a study by the University of Zurich now reveals. It includes data of 63 countries and demonstrates that during the 2008 economic crisis the number of all suicides associated with unemployment was nine times higher than previously believed.

Contact: Carlos Nordt
cnordt@bli.uzh.ch
41-443-842-408
University of Zurich

Public Release: 10-Feb-2015
mBio
Antiviral compound protects nonhuman primates against Ebola virus
Scientists protected 75 percent of rhesus monkeys infected with Ebola virus that were treated with a compound targeting the expression of VP24, a single Ebola virus protein -- suggesting that VP24 may hold the key to developing effective therapies for the deadly disease.
US Department of Defense, Joint Project Manager, Medical Countermeasure Systems

Contact: Caree Vander Linden
teresa.l.vanderlinden.civ@mail.mil
301-619-2285
US Army Medical Research Institute of Infectious Diseases

Public Release: 10-Feb-2015
mBio
Drug targeting Ebola virus protein VP24 shows promise in monkeys
An experimental medication that targets a protein in Ebola virus called VP24 protected 75 percent of a group of monkeys that were studied from Ebola virus infection, according to new research conducted by the US Army, in collaboration with Sarepta Therapeutics, Inc. The study was published this week in mBio, the online open-access journal of the American Society for Microbiology.

Contact: Aleea Kahn
akahn@asmusa.org
American Society for Microbiology

Public Release: 9-Feb-2015
Lancet Infectious Diseases
Immune biomarkers help predict early death, complications in HIV patients with TB
Reporting in a new study published online this week in The Lancet Infectious Diseases, researchers under the Botswana-UPenn Partnership at the University of Pennsylvania have identified immune biomarkers in patients with HIV and TB before they begin ART that could help distinguish which patients go on to develop IRIS or die after treatment.
National Institutes of Health, Penn Center for AIDS Research

Contact: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine

Public Release: 9-Feb-2015
PLOS Computational Biology
Using big data to detect disease outbreaks: Is it ethical?
Personal information taken from social media, blogs, page views and so on are used to detect disease outbreaks, however, does this violate our privacy, consent and trust?

Contact: Effy Vayena
vayena@ethik.uzh.ch
41-446-348-081
PLOS

Public Release: 5-Feb-2015
Lancet Infectious Diseases
Ebola: New studies model a deadly epidemic
Researchers from Arizona State University and Georgia State University are trying to better understand the epidemiology and control of Ebola Virus Disease in order to alleviate suffering and prevent future disease outbreaks from reaching the catastrophic proportions of the current crisis.

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University

Public Release: 5-Feb-2015
Stem Cell Reports
New source of cells for modeling malaria
MIT researchers have discovered a way to grow liver-like cells from induced pluripotent stem cells.
Bill and Melinda Gates Foundation, Singapore Agency for Science, Technology and Research, Howard Hughes Medical Institute.

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 5-Feb-2015
Stem Cell Reports
Malaria-in-a-dish paves the way for better treatments
Massachusetts Institute of Technology researchers have engineered a way to use human liver cells, derived from induced pluripotent stem cells, to screen potential antimalarial drugs and vaccines for their ability to treat the liver stage of malaria infection. The approach may offer new opportunities for personalized antimalarial drug testing and the development of more effective individually tailored drugs to combat the disease, which causes more than 500,000 deaths worldwide each year.

Contact: Joseph Caputo
jcaputo@cell.com
617-397-2802
Cell Press

Public Release: 5-Feb-2015
PLOS Computational Biology
Why do new strains of HIV spread slowly?
Most HIV epidemics are still dominated by the first strain that entered a particular population. New research published in PLOS Computational Biology offers an explanation of why the global mixing of HIV variants is so slow.

Contact: Viktor Müller
mueller.viktor@gmail.com
36-205-513-711
PLOS

Public Release: 4-Feb-2015
Pfizer Research Prize 2015 for Valérie D'Acremont
Valérie d'Acremont, clinical epidemiologiste at Swiss TPH, is one of the nine Pfizer Research Prize 2015 awardees for her paper on febrile illnesses published last year in the New England Journal of Medicine. The prize is one of the most prestigious prizes in Switzerland for a single research paper.

Contact: Christian Heuss
christian.heuss@swisstph.ch
41-612-548-683
Swiss Tropical and Public Health Institute

Showing releases 76-100 out of 979.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>